Search Results - "Gallagher, Kim P"

Refine Results
  1. 1

    Spontaneous thrombosis in mice carrying the factor V Leiden mutation by Cui, Jisong, Eitzman, Daniel T., Westrick, Randal J., Christie, Patricia D., Xu, Zuojun J., Yang, Angela Y., Purkayastha, Anjali A., Yang, Tony L., Metz, Alan L., Gallagher, Kim P., Tyson, Julia A., Rosenberg, Robert D., Ginsburg, David

    Published in Blood (15-12-2000)
    “…A polymorphism in coagulation factor V, factor V Leiden (FVL), is the major known genetic risk factor for thrombosis in humans. Approximately 10% of mutation…”
    Get full text
    Journal Article
  2. 2

    Spontaneous thrombosis in mice carrying the factor V Leiden mutation by Cui, Jisong, Eitzman, Daniel T., Westrick, Randal J., Christie, Patricia D., Xu, Zuojun J., Yang, Angela Y., Purkayastha, Anjali A., Yang, Tony L., Metz, Alan L., Gallagher, Kim P., Tyson, Julia A., Rosenberg, Robert D., Ginsburg, David

    Published in Blood (15-12-2000)
    “…A polymorphism in coagulation factor V, factor V Leiden (FVL), is the major known genetic risk factor for thrombosis in humans. Approximately 10% of mutation…”
    Get full text
    Journal Article
  3. 3

    Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits: Beneficial effects on left ventricular and myocyte function by SPINALE, F. G, WALKER, J. D, MUKHERJEE, R, IANNINI, J. P, KEEVER, A. T, GALLAGHER, K. P

    Published in Circulation (New York, N.Y.) (01-04-1997)
    “…Plasma levels of endothelin-1 (ET-1) are increased in patients and animals with severe congestive heart failure (CHF). It remains unknown, however, whether…”
    Get full text
    Journal Article
  4. 4

    Spatial and temporal characteristics of circumferential flow-function relations during acute myocardial ischemia in the conscious dog by Buda, A J, Shlafer, M, Gallagher, K P

    Published in The American heart journal (01-12-1988)
    “…In the anesthetized open-chest dog the ischemic area produced by coronary occlusion is surrounded by an area of nonischemic contractile dysfunction, identified…”
    Get more information
    Journal Article
  5. 5

    Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation by Simpson, P J, Mitsos, S E, Ventura, A, Gallagher, K P, Fantone, J C, Abrams, G D, Schork, M A, Lucchesi, B R

    Published in The American heart journal (01-01-1987)
    “…Prostacyclin (PGI2) and the stable PGI2 analogue SC39902 (6,9 alpha-epoxy,5S-fluoro-11 alpha, 15S-dehydroxyprosta-6,13E-dien-1-oic acid, sodium salt) were…”
    Get more information
    Journal Article
  6. 6

    Effects of endothelin ET A receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits by Ignasiak, Diane P, McClanahan, Thomas B, Saganek, Lori J, Potoczak, Ronald E, Hallak, Hussein, Gallagher, Kim P

    Published in European journal of pharmacology (05-03-1997)
    “…The objective of this study was to determine the in vivo effectiveness of the selective endothelin ET A receptor antagonist PD 156707 {sodium…”
    Get full text
    Journal Article
  7. 7

    The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosis by MCCLANAHAN, Thomas B, HICKS, Gary W, IGNASIAK, Diane P, BOUSLEY, Richard, MERTZ, Thomas E, JUNEAU, Paul, JANICZEK-DOLPHIN, Nancy, KIM, In-Chull, GALLAGHER, Kim P

    Published in Journal of thrombosis and thrombolysis (01-12-2000)
    “…Direct thrombin inhibitors represent a new class of drug that may offer a therapeutic alternative for the treatment and prevention of thrombembolic conditions,…”
    Get full text
    Journal Article
  8. 8

    Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: Comparison with inogatran by LIGUO CHI, MERTZ, Thomas E, ROGERS, Karen L, JANICZEK, Nancy, PENG, Yun-Wen, SAGANEK, Lori, BOUSLEY, Richard F, JUNEAU, Paul L, UPRICHARD, Andrew C. G, GALLAGHER, Kim P

    Published in Journal of thrombosis and thrombolysis (01-02-2001)
    “…LB-30057 (CI-1028) is a novel, orally bioavailable, direct thrombin inhibitor with a Ki of 0.38 nM against human thrombin. The effects of LB-30057 on thrombus…”
    Get full text
    Journal Article
  9. 9

    A novel model of venous thrombosis in the vena cava of rabbits by Chi, Liguo, Saganek, Lori J, Rogers, Karen L, Mertz, Thomas E, Metz, Alan L, Uprichard, Andrew C.G, Gallagher, Kim P

    “…The objective of this study was to develop and validate a new experimental model of venous thrombosis in the rabbit. A 3-cm length of siliconized PE tubing was…”
    Get full text
    Journal Article
  10. 10

    Myocardial contractility in a canine model of the brain-dead organ donor by Huber, T S, Groh, M A, Gallagher, K P, D'Alecy, L G

    Published in Critical care medicine (01-11-1993)
    “…To test the hypothesis that the induction and maintenance of brain death leads to a decrease in myocardial contractility. Prospective, randomized, controlled…”
    Get more information
    Journal Article
  11. 11

    Effects of nontransmural ischemia on inner and outer wall thickening in the canine left ventricle by Torry, R J, Myers, J H, Adler, A L, Liut, C L, Gallagher, K P

    Published in The American heart journal (01-11-1991)
    “…The effect of ischemic subendocardial dysfunction on contractile function in the normally perfused subepicardium remains controversial. Accordingly, regional…”
    Get more information
    Journal Article
  12. 12

    Effects of Endothelin-Receptor Antagonism with PD156707 on Myocardial Stunning in Swine by McClanahan, Thomas B, Mertz, Thomas E, Ignasiak, Diane P, Juneau, Paul L, Gallagher, Kim P

    Published in Journal of cardiovascular pharmacology (01-11-1996)
    “…SUMMARYEndothelin (ET) has been proposed to play a role in the pathogenesis of myocardial ischemia/reperfusion injury. The potential role of ET in myocardial…”
    Get full text
    Journal Article
  13. 13

    The regional effect of retrograde cardioplegia in areas of evolving ischemia by Iannettoni, M D, Rohs, Jr, T J, Gallagher, K P, Bolling, S F

    Published in Chest (01-11-1995)
    “…Retrograde cardioplegia (RCP) is often used for myocardial protection during coronary bypass grafting, but the regional effect of RCP in areas of evolving…”
    Get more information
    Journal Article
  14. 14

    Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injury by Lynch, M J, Grum, C M, Gallagher, K P, Bolling, S F, Deeb, G M, Morganroth, M L

    Published in The Journal of surgical research (01-05-1988)
    “…Ischemic-reperfusion lung injury is a factor potentially limiting the usefulness of distant organ procurement for heart-lung transplantation. Toxic oxygen…”
    Get more information
    Journal Article
  15. 15

    Hemodynamic effects of intraatrial administration of deferoxamine or deferoxamine-pentafraction conjugate to conscious dogs by Forder, J R, McClanahan, T B, Gallagher, K P, Hedlund, B E, Hallaway, P E, Shlafer, M

    Published in Journal of cardiovascular pharmacology (01-11-1990)
    “…Deferoxamine (DFX) is a specific Fe3+ chelator that is used to manage iron overload, and is being evaluated as an agent to reduce ischemic organ damage that…”
    Get more information
    Journal Article
  16. 16

    Subepicardial vasodilator reserve in the presence of critical coronary stenosis in dogs by Gallagher, Kim P., Folts, John D., Shebuski, Ronald J., Rankin, John H.G., Rowe, George G.

    Published in The American journal of cardiology (01-07-1980)
    “…Critical coronary stenosis is the term used to describe obstruction that eliminates reactive hyperemia presumably because downstream arterioles have dilated…”
    Get full text
    Journal Article
  17. 17

    A reversible pulmonary artery band: Preliminary experience by Rocchini, Albert P, Gundry, Steven R, Beekman, Robert H, Gallagher, Kim P, Heidelberger, Kathleen, Bove, Edward, Behrendt, Douglas M, Dysko, Robert C, Rosen, Karen

    “…Pulmonary artery banding has become an infrequently used surgical technique. However, if a band was developed that could be relieved without the need for open…”
    Get full text
    Journal Article
  18. 18

    Myocardial protection with preconditioning by LI, G. C, VASQUEZ, J. A, GALLAGHER, K. P, LUCCHESI, B. R

    Published in Circulation (New York, N.Y.) (01-08-1990)
    “…Myocardial preconditioning with brief coronary artery occlusions before a sustained ischemic period is reported to reduce infarct size. To determine the number…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Pretreatment with Endothelin-1 Mimics Ischemic Preconditioning Against Infarction in Isolated Rabbit Heart by Wang, Peipei, Gallagher, Kim P., Downey, James M., Cohen, Michael V.

    “…We have proposed that ischemic preconditioning in rabbit hearts is initiated by adenosine receptor stimulation resulting in activation of protein kinase C. If…”
    Get full text
    Journal Article